Showing results (611-620 of 690) with videos related to
Sort By:
Pageof 69
RMD Open|March 19, 2026
Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trialTeresa Holly, Marthe Kirkesaether Brun, Kristin Kaasen Jørgensen, et al.Medical Engineering & Physics|September 25, 2012
Concept and evaluation of an endaurally insertable middle-ear implantErich Goll, Ernst Dalhoff, Anthony W Gummer, et al.Journal of Internal Medicine|April 12, 2022
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trialMarthe Kirkesaether Brun, Guro Løvik Goll, Kristin Kaasen Jørgensen, et al.European Journal of Gastroenterology & Hepatology|July 27, 1999
Hepatitis C virus infection risk factors in patients admitted in hospital emergency departments in Picardy. Value of oriented screening based on recommendations of the 'Direction Générale de la Santé'D Capron, T Bensousan, J P Darchis, et al.Vaccines|December 28, 2019
Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune ResponsesMuktha S Natrajan, Nadine Rouphael, Lilin Lai, et al.NPJ Vaccines|August 30, 2022
The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccinationJohannes B Goll, Aarti Jain, Travis L Jensen, et al.Arthritis Research & Therapy|October 18, 2025
A DNA methylation-based algorithm for diagnosing rheumatoid arthritisEspen Riskedal, Astanand Jugessur, Silje Watterdal Syversen, et al.Nature|February 22, 2023
Diagnosing destabilization risk in global land carbon sinksMarcos Fernández-Martínez, Josep Peñuelas, Frederic Chevallier, et al.The Lancet. Rheumatology|February 25, 2024
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trialsMarthe Kirkesæther Brun, Johanna E Gehin, Kristin Hammersbøen Bjørlykke, et al.The Journal of Biological Chemistry|February 14, 2014
Coregulator control of androgen receptor action by a novel nuclear receptor-binding motifKatja Jehle, Laura Cato, Antje Neeb, et al.Pageof 69